ruthenium has been researched along with Koch's Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista, AA; Chorilli, M; da Silva, MM; da Silva, PB; de Freitas, ES; de Oliveira Lopes, E; Leite, CQ; Pavan, FR | 1 |
| Aguiar, Id; da Silva, AC; Franco, DW; Lopes, ÉO; Lopes, LG; Marino, LB; Pavan, FR; Roveda, AC; Tavares, A | 1 |
| Barbosa, MI; Batista, AA; Ellena, J; Franzblau, SG; Gambino, D; Leite, CQ; Leite, SR; Moreno, V; Pavan, FR; Poelhsitz, GV; Sato, LS | 1 |
3 other study(ies) available for ruthenium and Koch's Disease
| Article | Year |
|---|---|
Nanostructured lipid systems as a strategy to improve the in vitro cytotoxicity of ruthenium(II) compounds.
Topics: Humans; Lipids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanostructures; Ruthenium; Tuberculosis | 2014 |
Antitubercular activity of Ru (II) isoniazid complexes.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ruthenium; Tuberculosis; Vero Cells | 2015 |
Ruthenium(II) phosphine/diimine/picolinate complexes: inorganic compounds as agents against tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Crystallography, X-Ray; Humans; Imines; Mice; Models, Molecular; Mycobacterium tuberculosis; Organometallic Compounds; Phosphines; Picolinic Acids; Ruthenium; Tuberculosis | 2011 |